Hengli Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hengli Zhang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ambika G. Bajpayee
Department of Bioengineering, Northeastern University, Boston, USA
4 shared publications - Chenzhen Zhang
Department of Bioengineering, Northeastern University, Boston, MA 02115, USA
2 shared publications Helna M. Baby
Department of Bioengineering, Northeastern University, Boston, MA, USA
2 shared publications- Héctor A. Millán Cotto
Department of Bioengineering, Northeastern University, Boston, MA, USA
2 shared publications - Bill Hakim
Department of Bioengineering, Northeastern University
1 shared publication Chenzhen Zhang
Department of Bioengineering, Northeastern University, Boston, MA, USA
1 shared publication
Latest Publications
- Open Access
- 9 May 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 217, 665-679
Charge-engineered microparticles for targeted delivery of RhoA activator to nucleus pulposus
- 9 May 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 217, 665-679
Open AccessCharge-engineered microparticles for targeted delivery of RhoA activator to nucleus pulposus
- Open Access
- 13 November 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (44) , 25664-25679
Extended osteoarthritis pain relief with neosaxitoxin using alginate-core polymeric microparticles
We developed a sustained release alginate-core polymeric microparticle formulation (NSTX-AlgPLGA-MP) to extend the analgesic effect of Neosaxitoxin (NSTX) for osteoarthritis (OA) pain from hours to approximately one week.
- 13 November 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (44) , 25664-25679
Open AccessExtended osteoarthritis pain relief with neosaxitoxin using alginate-core polymeric microparticles
We developed a sustained release alginate-core polymeric microparticle formulation (NSTX-AlgPLGA-MP) to extend the analgesic effect of Neosaxitoxin (NSTX) for osteoarthritis (OA) pain from hours to approximately one week.
- Top Cited PapersOpen Access
- 31 March 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 33 (7) , 835-847
Cartilage-targeting exosomes for delivery of receptor antagonist of interleukin-1 in osteoarthritis treatment
- 31 March 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 33 (7) , 835-847
Top Cited PapersOpen AccessCartilage-targeting exosomes for delivery of receptor antagonist of interleukin-1 in osteoarthritis treatment
- 23 November 2023
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (3) , 634-649
Milk exosomes anchored with hydrophilic and zwitterionic motifs enhance mucus permeability for applications in oral gene delivery
Surface modification of milk exosomes with hydrophilic and zwitterionic peptides improves stability in the gastrointestinal tract, permeability through intestinal mucus, and uptake into epithelial cells, thereby markedly increasing the efficiency of oral administration for gene delivery.
- 23 November 2023
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (3) , 634-649
Milk exosomes anchored with hydrophilic and zwitterionic motifs enhance mucus permeability for applications in oral gene delivery
Surface modification of milk exosomes with hydrophilic and zwitterionic peptides improves stability in the gastrointestinal tract, permeability through intestinal mucus, and uptake into epithelial cells, thereby markedly increasing the efficiency of oral administration for gene delivery.